A 7-year-old boy has difficulty distinguishing red and green colors. His maternal grandfather and maternal uncle cannot distinguish these colors.
XLR; OPN1LW (L-opsin, the red cone pigment) and OPN1MW (M-opsin, the green cone pigment) in a tandem array on Xq28. Recombination between the two near-identical genes deletes a gene or makes a hybrid one, so one cone class is missing or spectrally shifted.
L-opsin and M-opsin are the light-absorbing pigments of the long-wavelength (red) and middle-wavelength (green) cones. Their genes sit in a tandem array on the X chromosome, usually one OPN1LW followed by one or more OPN1MW, and share almost 98% sequence identity. One upstream enhancer, the locus control region, lets each cone express a single gene, and only the first two genes in the array are expressed.
The near-identity lets the genes recombine unequally and convert one another, which deletes whole genes and creates hybrid L/M genes. The cone mix follows the first two genes:
- Deutan (no M cones): both expressed genes encode L pigments, or the array holds a single L gene. Identical pigments give deuteranopia; L pigments that differ in peak sensitivity give deuteranomaly. Deutan defects are the most common form, about 6% of males.
- Protan (no L cones): the same arrangements built from M pigments give protanopia or protanomaly.
Less often, an inactivating variant in one of the first two genes, or an exon 3 haplotype that makes the transcript skip exon 3, has the same effect. Deleting the locus control region silences both genes and causes a different disorder, blue cone monochromacy, with poor visual acuity.
- Red-green color blindness (most common: deuteranomaly)
- Affects ~8% of males, ~0.4% of females (homozygotes or skewed X-inactivation)
- Does not affect visual acuity
- Ishihara pseudoisochromatic plates for red-green screening
- Anomaloscope (Nagel) color matching as the reference test to confirm and classify the deficiency type
- Molecular testing of the OPN1LW/OPN1MW opsin gene array is available but rarely needed clinically
- No cure; supportive measures and counseling about the benign, stable nature of the condition
- Practical adaptations (labeling, assistive apps, color-correcting filters with variable benefit) and awareness of occupational color-vision requirements